Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Midbrain MRI assessments in progressive supranuclear palsy subtypes.

Picillo M, Tepedino MF, Abate F, Erro R, Ponticorvo S, Tartaglione S, Volpe G, Frosini D, Cecchi P, Cosottini M, Ceravolo R, Esposito F, Pellecchia MT, Barone P, Manara R.

J Neurol Neurosurg Psychiatry. 2019 Sep 16. pii: jnnp-2019-321354. doi: 10.1136/jnnp-2019-321354. [Epub ahead of print]

PMID:
31527182
2.

PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts.

Amodio G, Moltedo O, Fasano D, Zerillo L, Oliveti M, Di Pietro P, Faraonio R, Barone P, Pellecchia MT, De Rosa A, De Michele G, Polishchuk E, Polishchuk R, Bonifati V, Nitsch L, Pierantoni GM, Renna M, Criscuolo C, Paladino S, Remondelli P.

Front Neurosci. 2019 Jun 27;13:673. doi: 10.3389/fnins.2019.00673. eCollection 2019.

3.

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M.

Lancet Neurol. 2019 Aug;18(8):748-759. doi: 10.1016/S1474-4422(19)30140-1. Epub 2019 Jun 19.

PMID:
31229470
4.

From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations.

Erro R, Picillo M, Manara R, Pellecchia MT, Barone P.

Parkinsonism Relat Disord. 2019 May 23. pii: S1353-8020(19)30246-9. doi: 10.1016/j.parkreldis.2019.05.025. [Epub ahead of print] No abstract available.

PMID:
31151786
5.

Parkinson's disease management and impulse control disorders: current state and future perspectives.

Vitale C, Amboni M, Erro R, Picillo M, Pellecchia MT, Barone P, Trojano L, Santangelo G.

Expert Rev Neurother. 2019 Jun;19(6):495-508. doi: 10.1080/14737175.2019.1620603. Epub 2019 May 31.

PMID:
31148487
6.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Jul;34(7):975-984. doi: 10.1002/mds.27701. Epub 2019 Apr 29. No abstract available.

PMID:
31034671
7.

Motor, cognitive and behavioral differences in MDS PSP phenotypes.

Picillo M, Cuoco S, Tepedino MF, Cappiello A, Volpe G, Erro R, Santangelo G, Pellecchia MT, Barone P; PSP Salerno study group.

J Neurol. 2019 Jul;266(7):1727-1735. doi: 10.1007/s00415-019-09324-x. Epub 2019 Apr 15.

PMID:
30989369
8.

Comparing postural instability and gait disorder and akinetic-rigid subtyping of Parkinson disease and their stability over time.

Erro R, Picillo M, Amboni M, Savastano R, Scannapieco S, Cuoco S, Santangelo G, Vitale C, Pellecchia MT, Barone P.

Eur J Neurol. 2019 Sep;26(9):1212-1218. doi: 10.1111/ene.13968. Epub 2019 May 17.

PMID:
30985953
9.

The language profile of progressive supranuclear palsy.

Catricalà E, Boschi V, Cuoco S, Galiano F, Picillo M, Gobbi E, Miozzo A, Chesi C, Esposito V, Santangelo G, Pellecchia MT, Borsa VM, Barone P, Garrard P, Iannaccone S, Cappa SF.

Cortex. 2019 Jun;115:294-308. doi: 10.1016/j.cortex.2019.02.013. Epub 2019 Feb 22.

PMID:
30884283
10.

Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy.

Rusz J, Tykalová T, Salerno G, Bancone S, Scarpelli J, Pellecchia MT.

J Neurol. 2019 Jun;266(6):1394-1404. doi: 10.1007/s00415-019-09271-7. Epub 2019 Mar 11.

PMID:
30859316
11.

Serum miR-30c-5p is a potential biomarker for multiple system atrophy.

Vallelunga A, Iannitti T, Dati G, Capece S, Maugeri M, Tocci E, Picillo M, Volpe G, Cozzolino A, Squillante M, Cicarelli G, Barone P, Pellecchia MT.

Mol Biol Rep. 2019 Apr;46(2):1661-1666. doi: 10.1007/s11033-019-04614-z. Epub 2019 Feb 27.

PMID:
30810945
12.

Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI.

Ponticorvo S, Manara R, Pfeuffer J, Cappiello A, Cuoco S, Pellecchia MT, Saponiero R, Troisi D, Cassandro C, John M, Scarpa A, Cassandro E, Di Salle F, Esposito F.

Hum Brain Mapp. 2019 Jun 1;40(8):2475-2487. doi: 10.1002/hbm.24538. Epub 2019 Feb 4.

PMID:
30715769
13.

SPECT Molecular Imaging in Familial Parkinson's Disease.

Varrone A, Pellecchia MT.

Int Rev Neurobiol. 2018;142:225-260. doi: 10.1016/bs.irn.2018.09.004. Epub 2018 Oct 30. Review.

PMID:
30409254
14.

Theory of mind and joint action in Parkinson's disease.

Fabbri M, Vitale C, Cuoco S, Beracci A, Calabrese R, Cordella M, Mazzotta R, Barone P, Pellecchia MT, Santangelo G.

Cogn Affect Behav Neurosci. 2018 Dec;18(6):1320-1337. doi: 10.3758/s13415-018-0642-0.

PMID:
30259349
15.

Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy.

Monzio Compagnoni G, Kleiner G, Bordoni A, Fortunato F, Ronchi D, Salani S, Guida M, Corti C, Pichler I, Bergamini C, Fato R, Pellecchia MT, Vallelunga A, Del Sorbo F, Elia A, Reale C, Garavaglia B, Mora G, Albanese A, Cogiamanian F, Ardolino G, Bresolin N, Corti S, Comi GP, Quinzii CM, Di Fonzo A.

Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3588-3597. doi: 10.1016/j.bbadis.2018.09.018. Epub 2018 Sep 19.

PMID:
30254015
16.

Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.

J Neurol. 2018 Nov;265(11):2602-2613. doi: 10.1007/s00415-018-9038-x. Epub 2018 Sep 3.

PMID:
30178175
17.

MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes.

Picillo M, Erro R, Cuoco S, Tepedino MF, Manara R, Pellecchia MT, Barone P; PSP Salerno Study Group.

Mov Disord. 2018 Aug;33(8):1361-1365. doi: 10.1002/mds.27408. Epub 2018 Jul 8. No abstract available.

PMID:
29984518
18.

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.

Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR; European MSA Study Group (EMSA-SG).

Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8.

PMID:
29910157
19.

Cognitive correlates of "pure apathy" in Parkinson's disease.

Santangelo G, D'Iorio A, Maggi G, Cuoco S, Pellecchia MT, Amboni M, Barone P, Vitale C.

Parkinsonism Relat Disord. 2018 Aug;53:101-104. doi: 10.1016/j.parkreldis.2018.04.023. Epub 2018 Apr 24.

PMID:
29706433
20.

Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations.

Fasano D, Parisi S, Pierantoni GM, De Rosa A, Picillo M, Amodio G, Pellecchia MT, Barone P, Moltedo O, Bonifati V, De Michele G, Nitsch L, Remondelli P, Criscuolo C, Paladino S.

Cell Death Dis. 2018 Mar 7;9(3):385. doi: 10.1038/s41419-018-0410-7.

21.

Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.

Picillo M, Pivonello R, Santangelo G, Pivonello C, Savastano R, Auriemma R, Amboni M, Scannapieco S, Pierro A, Colao A, Barone P, Pellecchia MT.

PLoS One. 2017 Oct 24;12(10):e0186508. doi: 10.1371/journal.pone.0186508. eCollection 2017.

22.

Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease.

Picillo M, Barone P, Pellecchia MT.

Mov Disord Clin Pract. 2017 Aug 21;4(5):652-662. doi: 10.1002/mdc3.12521. eCollection 2017 Sep-Oct. Review.

23.

Assessment of apathy minimising the effect of motor dysfunctions in Parkinson's disease: a validation study of the dimensional apathy scale.

Santangelo G, D'Iorio A, Piscopo F, Cuoco S, Longo K, Amboni M, Baiano C, Tafuri D, Pellecchia MT, Barone P, Vitale C.

Qual Life Res. 2017 Sep;26(9):2533-2540. doi: 10.1007/s11136-017-1569-6. Epub 2017 Apr 7.

PMID:
28389975
24.

Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease.

Picillo M, Santangelo G, Erro R, Cozzolino A, Amboni M, Vitale C, Barone P, Pellecchia MT.

Parkinsonism Relat Disord. 2017 Apr;37:106-110. doi: 10.1016/j.parkreldis.2017.02.010. Epub 2017 Feb 9.

PMID:
28214265
25.

The relevance of gender in Parkinson's disease: a review.

Picillo M, Nicoletti A, Fetoni V, Garavaglia B, Barone P, Pellecchia MT.

J Neurol. 2017 Aug;264(8):1583-1607. doi: 10.1007/s00415-016-8384-9. Epub 2017 Jan 4. Review.

PMID:
28054129
26.

Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus.

Criscuolo C, D'Amico A, Peluso S, Popolizio T, Pellecchia MT.

Parkinsonism Relat Disord. 2017 Jan;34:75-76. doi: 10.1016/j.parkreldis.2016.11.007. Epub 2016 Nov 18. No abstract available.

PMID:
27887894
27.

Caffeine consumption and the 4-year progression of de novo Parkinson's disease.

Moccia M, Erro R, Picillo M, Vitale C, Longo K, Amboni M, Pellecchia MT, Barone P.

Parkinsonism Relat Disord. 2016 Nov;32:116-119. doi: 10.1016/j.parkreldis.2016.08.005. Epub 2016 Aug 4.

PMID:
27622969
28.

A genome-wide association study in multiple system atrophy.

Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O'Sullivan SS, Wood NW, Traynor BJ, Ferrucci L, Federoff HJ, Mhyre TR, Morris HR, Deuschl G, Quinn N, Widner H, Albanese A, Infante J, Bhatia KP, Poewe W, Oertel W, Höglinger GU, Wüllner U, Goldwurm S, Pellecchia MT, Ferreira J, Tolosa E, Bloem BR, Rascol O, Meissner WG, Hardy JA, Revesz T, Holton JL, Gasser T, Wenning GK, Singleton AB, Houlden H; European Multiple System Atrophy Study Group and the UK Multiple System Atrophy Study Group.

Neurology. 2016 Oct 11;87(15):1591-1598. Epub 2016 Sep 14.

29.

The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study.

Erro R, Picillo M, Vitale C, Amboni M, Moccia M, Santangelo G, Pellecchia MT, Barone P.

Eur J Neurol. 2016 Nov;23(11):1673-1679. doi: 10.1111/ene.13106. Epub 2016 Jul 20.

PMID:
27435448
30.

Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study.

Pellecchia MT, Savastano R, Moccia M, Picillo M, Siano P, Erro R, Vallelunga A, Amboni M, Vitale C, Santangelo G, Barone P.

J Neural Transm (Vienna). 2016 Dec;123(12):1399-1402. doi: 10.1007/s00702-016-1622-6. Epub 2016 Sep 28.

PMID:
27682634
31.

Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F, Criscuolo C, Moccia M, De Rosa A, Sorbera C, Bentivoglio AR, Barone P, De Michele G, Pellecchia MT, Valente EM.

Neurology. 2016 Oct 4;87(14):1436-1441. Epub 2016 Sep 2.

32.

Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment.

Barone P, Santangelo G, Amboni M, Pellecchia MT, Vitale C.

Lancet Neurol. 2016 Sep;15(10):1063-74. doi: 10.1016/S1474-4422(16)30173-9. Epub 2016 Aug 8. Review.

PMID:
27571158
33.

Progressive Supranuclear Palsy-Like Phenotype in a GBA E326K Mutation Carrier.

Picillo M, Petrucci S, Valente EM, Pappatà S, Squame F, Ginevrino M, Pace L, Barone P, Pellecchia MT.

Mov Disord Clin Pract. 2016 Jul 27;4(3):444-446. doi: 10.1002/mdc3.12406. eCollection 2017 May-Jun. No abstract available.

34.

Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS).

Santangelo G, Falco F, D'Iorio A, Cuoco S, Raimo S, Amboni M, Pellecchia MT, Longo K, Vitale C, Barone P.

J Neurol Sci. 2016 Aug 15;367:158-61. doi: 10.1016/j.jns.2016.06.008. Epub 2016 Jun 4.

PMID:
27423582
35.

Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease.

Moccia M, Pellecchia MT, Spina E, Barone P, Vitale C.

Cell Biochem Biophys. 2016 Jun;74(2):91-2. doi: 10.1007/s12013-015-0717-2. No abstract available.

PMID:
27286855
36.

Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease.

Erro R, Picillo M, Vitale C, Palladino R, Amboni M, Moccia M, Pellecchia MT, Barone P.

Parkinsonism Relat Disord. 2016 Jul;28:137-40. doi: 10.1016/j.parkreldis.2016.04.026. Epub 2016 Apr 28.

37.

Gender and non motor fluctuations in Parkinson's disease: A prospective study.

Picillo M, Palladino R, Moccia M, Erro R, Amboni M, Vitale C, Barone P, Pellecchia MT.

Parkinsonism Relat Disord. 2016 Jun;27:89-92. doi: 10.1016/j.parkreldis.2016.04.001. Epub 2016 Apr 4.

PMID:
27066847
38.

Early Ataxia and Subsequent Parkinsonism: PLA2G6 Mutations Cause a Continuum Rather Than Three Discrete Phenotypes.

Erro R, Balint B, Kurian MA, Brugger F, Picillo M, Barone P, Bhatia KP, Pellecchia MT.

Mov Disord Clin Pract. 2016 Mar 31;4(1):125-128. doi: 10.1002/mdc3.12319. eCollection 2017 Jan-Feb.

39.

Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.

Picillo M, Santangelo G, Moccia M, Erro R, Amboni M, Prestipino E, Longo K, Vitale C, Spina E, Orefice G, Barone P, Pellecchia MT.

J Neural Transm (Vienna). 2016 Apr;123(4):371-7. doi: 10.1007/s00702-015-1502-5. Epub 2016 Jan 6.

PMID:
26739446
40.

Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.

De Rosa A, Pellegrino T, Pappatà S, Pellecchia MT, Peluso S, Saccà F, Barone P, Cuocolo A, De Michele G.

J Nucl Cardiol. 2017 Feb;24(1):103-107. doi: 10.1007/s12350-015-0332-z. Epub 2015 Dec 1.

PMID:
26626785
41.

A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease.

Moccia M, Erro R, Picillo M, Santangelo G, Spina E, Allocca R, Longo K, Amboni M, Palladino R, Assante R, Pappatà S, Pellecchia MT, Barone P, Vitale C.

Sleep. 2016 Feb 1;39(2):405-12. doi: 10.5665/sleep.5452.

42.

On the relationship between side of onset and cognition in Parkinson disease.

Erro R, Spina E, Barone P, Pellecchia MT.

Parkinsonism Relat Disord. 2015 Nov;21(11):1391-2. doi: 10.1016/j.parkreldis.2015.09.052. Epub 2015 Oct 1.

PMID:
26454704
43.

Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.

Santangelo G, Vitale C, Picillo M, Moccia M, Cuoco S, Longo K, Pezzella D, di Grazia A, Erro R, Pellecchia MT, Amboni M, Trojano L, Barone P.

Parkinsonism Relat Disord. 2015 Oct;21(10):1219-26. doi: 10.1016/j.parkreldis.2015.08.024. Epub 2015 Aug 21.

PMID:
26321021
44.

Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers.

Picillo M, De Rosa A, Pellecchia MT, Criscuolo C, Amboni M, Erro R, Bonifati V, De Michele G, Barone P.

Mov Disord Clin Pract. 2015 Jul 25;2(4):413-416. doi: 10.1002/mdc3.12183. eCollection 2015 Dec.

45.

Neuropsychiatric disorders in Cushing's syndrome.

Pivonello R, Simeoli C, De Martino MC, Cozzolino A, De Leo M, Iacuaniello D, Pivonello C, Negri M, Pellecchia MT, Iasevoli F, Colao A.

Front Neurosci. 2015 Apr 20;9:129. doi: 10.3389/fnins.2015.00129. eCollection 2015. Review.

46.

Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.

Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, Erro R, Longo K, Vicidomini C, Pellecchia MT, Amboni M, Brunetti A, Salvatore M, Barone P, Pappatà S.

Parkinsonism Relat Disord. 2015 May;21(5):489-93. doi: 10.1016/j.parkreldis.2015.02.015. Epub 2015 Feb 25.

PMID:
25753457
47.

Increased bilirubin levels in de novo Parkinson's disease.

Moccia M, Picillo M, Erro R, Longo K, Amboni M, Santangelo G, Palladino R, Allocca R, Caporale O, Triassi M, Pellecchia MT, Barone P, Vitale C.

Eur J Neurol. 2015 Jun;22(6):954-9. doi: 10.1111/ene.12688. Epub 2015 Mar 5.

PMID:
25740378
48.

Early cues to detect atypical panthothenate kinase-associated neurodegeneration.

Moccia M, Cozzolino A, Cicarelli G, Barone P, Pellecchia MT.

J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):e78-9. doi: 10.1176/appi.neuropsych.13120375. No abstract available.

PMID:
25716508
49.

Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease.

Erro R, Picillo M, Amboni M, Moccia M, Vitale C, Longo K, Pellecchia MT, Santangelo G, Martinez-Martin P, Chaudhuri KR, Barone P.

Mov Disord. 2015 Mar;30(3):373-8. doi: 10.1002/mds.26076. Epub 2015 Feb 4.

PMID:
25648938
50.

Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.

Pellecchia MT, Picillo M, Santangelo G, Longo K, Moccia M, Erro R, Amboni M, Vitale C, Vicidomini C, Salvatore M, Barone P, Pappatà S.

Acta Neurol Scand. 2015 May;131(5):275-81. doi: 10.1111/ane.12365. Epub 2015 Feb 3.

PMID:
25644029

Supplemental Content

Loading ...
Support Center